{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:45:11Z","timestamp":1780461911344,"version":"3.54.1"},"reference-count":108,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["autonomicneuroscience.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autonomic Neuroscience"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.autneu.2006.07.009","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T11:50:19Z","timestamp":1156506619000},"page":"3-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":173,"title":["Treatment of nausea and vomiting: Gaps in our knowledge"],"prefix":"10.1016","volume":"129","author":[{"given":"Gareth J.","family":"Sanger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.R.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autneu.2006.07.009_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000087979","article-title":"5-HT3-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment","volume":"69","author":"Aapro","year":"2005","journal-title":"Oncology"},{"key":"10.1016\/j.autneu.2006.07.009_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00258206","article-title":"High-dose dexamethasone for prevention of cisplatin-induced vomiting","volume":"7","author":"Aaapro","year":"1981","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1748-1716.1973.tb05472.x","article-title":"Vomiting and reflex vagal relaxation of the stomach elicited from heart receptors in the cat","volume":"88","author":"Abrahamsson","year":"1973","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.autneu.2006.07.009_bib4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/bjc.1995.452","article-title":"Comparative efficacy of a single oral dose of ondansetron and of buspirone against cisplatin-induced emesis in cancer patients","volume":"72","author":"Alfieri","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.autneu.2006.07.009_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.autneu.2006.01.008","article-title":"Signals for nausea and emesis: implications for models of upper gastrointestinal diseases","volume":"125","author":"Andrews","year":"2006","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2006.07.009_bib6","series-title":"Neuroanatomy and Physiology of Abdominal Vagal Afferents","first-page":"280","author":"Andrews","year":"1992"},{"key":"10.1016\/j.autneu.2006.07.009_bib7","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-3-642-18891-6_12","article-title":"The role of tachykinins and the tachykinin NK1 receptor in nausea and emesis","author":"Andrews","year":"2004"},{"key":"10.1016\/j.autneu.2006.07.009_bib8","series-title":"Emesis and Anti-cancer Therapy: Mechanisms and Treatment","author":"Andrews","year":"1993"},{"key":"10.1016\/j.autneu.2006.07.009_bib10","series-title":"Fatigue in Cancer","first-page":"51","article-title":"Mechanisms and models of fatigue associated with cancer and its treatment: evidence from preclinical and clinical studies","author":"Andrews","year":"2004"},{"key":"10.1016\/j.autneu.2006.07.009_bib11","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa032196","article-title":"A factorial trial of six interventions for the prevention of postoperative nausea and vomiting","volume":"350","author":"Apfel","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autneu.2006.07.009_bib12","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1399-6576.2004.00527.x","article-title":"Betamethasone does not prevent nausea and vomiting induced by ipecacuanha","volume":"48","author":"Axelsson","year":"2003","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.autneu.2006.07.009_bib13","first-page":"728","article-title":"Letter","volume":"301","author":"Baker","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autneu.2006.07.009_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1566-0702(00)00221-6","article-title":"Pyrogenic signaling via vagal afferents: what stimulates their receptors?","volume":"85","author":"Blatteis","year":"2000","journal-title":"Auton. Neurosci. Basic Clin."},{"key":"10.1016\/j.autneu.2006.07.009_bib15","unstructured":"Bountra, C., Bays, D.E. 1998. Use of GABA agonists for treating emesis. United States Patent, 5.719, 185."},{"key":"10.1016\/j.autneu.2006.07.009_bib16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1152\/jn.1988.59.2.358","article-title":"Excitation of area postrema neurons by transmitters, peptides and cyclic nucleotides","volume":"59","author":"Carpenter","year":"1988","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.autneu.2006.07.009_bib17","first-page":"G130","article-title":"Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health","volume":"284","author":"Chial","year":"2003","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.autneu.2006.07.009_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(71)90139-7","article-title":"Side effects of anti-emetics: results of a class experiment","volume":"14","author":"Clarke","year":"1971","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0028-3908(86)90030-4","article-title":"5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis","volume":"25","author":"Costall","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.autneu.2006.07.009_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0022-3565(25)31039-6","article-title":"Naloxone antagonizes narcotic self blockade of emesis in the cat","volume":"203","author":"Costello","year":"1977","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.autneu.2006.07.009_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0893-133X(00)00197-4","article-title":"Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB1 receptor antagonist\/inverse agonist SR141716A","volume":"24","author":"Darmani","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.autneu.2006.07.009_bib22","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s007020050222","article-title":"The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew)","volume":"106","author":"Darmani","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.autneu.2006.07.009_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0306-4522(03)00327-0","article-title":"Growth hormone secretagogue receptors in the rat and human gastrointestinal tract and the effects of ghrelin","volume":"120","author":"Dass","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.autneu.2006.07.009_bib24","series-title":"Serotonin and the Scientific Basis of Anti-Emetic Therapy","first-page":"9","article-title":"Emesis research: a concise history of the critical concepts and experiments","author":"Davis","year":"1995"},{"key":"10.1016\/j.autneu.2006.07.009_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00280-005-1033-0","article-title":"Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?","volume":"56","author":"de Wit","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0028-3908(92)90158-L","article-title":"The effect of systemic administration of baclofen on food intake in rats","volume":"31","author":"Ebenezer","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.autneu.2006.07.009_bib27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1152\/jn.1995.73.2.907","article-title":"Cannabioid agonists inhibit activation of 5-HT3 receptors in rat nodose ganglion neurons","volume":"73","author":"Fan","year":"1995","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.autneu.2006.07.009_bib28","first-page":"187","article-title":"Cisplatin-induced emesis in the ferret: a new animal model","volume":"66","author":"Florczyk","year":"1982","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.autneu.2006.07.009_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejon.2004.03.006","article-title":"Nausea: the neglected symptom?","volume":"9","author":"Foubert","year":"2005","journal-title":"Eur. J. Oncol. Nurs."},{"key":"10.1016\/j.autneu.2006.07.009_bib30","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1046\/j.1365-2036.2002.01240.x","article-title":"Domperidone is more effective than cisapride in children with diabetic gastroparesis","volume":"16","author":"Franzese","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"Suppl 2","key":"10.1016\/j.autneu.2006.07.009_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2036.1999.00002.x-i2","article-title":"Roles played by 5-hydroxytryptamine in the physiology of the bowel","volume":"13","author":"Gershon","year":"1999","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.autneu.2006.07.009_bib32","unstructured":"Gill, C.H., Moore, S., Rance, K., Yusaf, S., Holbrook, J., Sanger, G.J., Gunthorpe, M.J., 2006. Functional Characterisation of Novel Human 5-HT3 Receptor Subunits (HTR3C-E). Proceedings of the British Pharmacology Society at http:\/\/www.pa2online.org\/abstracts\/Vol3Issue4abst177P."},{"key":"10.1016\/j.autneu.2006.07.009_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0028-3908(71)90011-6","article-title":"Drug-induced depression of gamma efferent activity. 3. Viscero\u2013somatic reflex action of phenyldiguanide, veratridine and 5-hydroxytryptamine","volume":"10","author":"Ginzel","year":"1971","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.autneu.2006.07.009_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1566-0702(00)00219-8","article-title":"Vagal immune-to-brain communication: a visceral chemosensory pathway","volume":"85","author":"Goehler","year":"2000","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2006.07.009_bib36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1365-2125.1997.00606.x","article-title":"Comparison of the effects of a selective muscarininc receptor antagonist and hyoscine (scopolamine)on motion sickness, skin conductance and heart rate","volume":"43","author":"Golding","year":"1997","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib37","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM198110153051601","article-title":"Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting","volume":"305","author":"Gralla","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autneu.2006.07.009_bib38","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1200\/JCO.1999.17.9.2971","article-title":"Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines","volume":"17","author":"Gralla","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.autneu.2006.07.009_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.autneu.2006.01.009","article-title":"Signalling the state of the digestive tract","volume":"125","author":"Grundy","year":"2006","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2006.07.009_bib40","first-page":"463","article-title":"Involvement of 5-HT1A and 5-HT2 receptors in cisplatin-induced emesis in dogs","volume":"46","author":"Gupta","year":"2002","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib41","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0959-8049(02)00674-3","article-title":"Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists","volume":"39","author":"Hesketh","year":"2003","journal-title":"Eur. J. Cancer"},{"issue":"8A","key":"10.1016\/j.autneu.2006.07.009_bib42","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1016\/S0002-9343(01)00849-X","article-title":"Central neurocircuitry associated with emesis","volume":"111","author":"Hornby","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.autneu.2006.07.009_bib43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/bjc.1993.295","article-title":"Endogenous cortisol exerts antiemetic effects similar to that of endogenous corticosteroids","volume":"68","author":"Hursti","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.autneu.2006.07.009_bib44","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/(SICI)1098-2396(199611)24:3<224::AID-SYN4>3.0.CO;2-G","article-title":"Distribution of D1\u2013D4 receptor subtypes in human dorsal vagal complex","volume":"24","author":"Hyde","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.autneu.2006.07.009_bib45","first-page":"528","article-title":"Randomized study of dexamethasone treatment for delayed emesis, anorexia and fatigue induced by irinotecan","volume":"11","author":"Inoue","year":"2003","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.autneu.2006.07.009_bib46","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bjp.0705507","article-title":"In vivo characterisation of 5-HT1A receptor-mediated gastric relaxation in conscious dogs","volume":"140","author":"Janssen","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-1119(03)00803-5","article-title":"A cluster of novel serotonin receptor 3-like genes on human chromosome 3","volume":"319","author":"Kamovsky","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.autneu.2006.07.009_bib48","first-page":"317","article-title":"Effect of baclofen on emesis and 24-hour esophageal pH in neurologically impaired children with gastroesophageal reflux disease","volume":"38","author":"Kawai","year":"2004","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.autneu.2006.07.009_bib49","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1152\/ajpregu.00572.2003","article-title":"A paracrine signaling role for serotonin in rat taste buds:expression and localization of serotonin receptor subtypes","volume":"286","author":"Kaya","year":"2004","journal-title":"Am. J. Physiol., Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.autneu.2006.07.009_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0165-6147(92)90012-U","article-title":"Sickness behaviour as a new target for drug development","volume":"13","author":"Kent","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.autneu.2006.07.009_bib51","first-page":"85","article-title":"Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-risk chemotherapy","volume":"13","author":"Kris","year":"2005","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.autneu.2006.07.009_bib52","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10517-005-0344-9","article-title":"Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart","volume":"139","author":"Krylatov","year":"2005","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.autneu.2006.07.009_bib53","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00004714-199808000-00002","article-title":"A Canadian multicenter study of three fixed doses of controlled release ipsapirone in outpatients with moderate to severe depression","volume":"18","author":"Lapierre","year":"1998","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib54","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0016-5085(99)70400-2","article-title":"Activation of the GABAB receptor inhibits transient lower esophageal sphincter relaxations in dogs","volume":"117","author":"Lehmann","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autneu.2006.07.009_bib55","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1053\/gast.2002.36025","article-title":"Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs","volume":"123","author":"Lehmann","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autneu.2006.07.009_bib56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bjp.0704506","article-title":"CB1 receptor antagonist SR141716A increases capsaicin-evoked release of substance P from the adult mouse spinal cord","volume":"135","author":"Lever","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib57","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0889-8553(03)00045-1","article-title":"Cyclic vomiting syndrome: a brain\u2013gut disorder","volume":"32","author":"Li","year":"2003","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.autneu.2006.07.009_bib58","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00280-005-0179-0","article-title":"Ghrelin alleviates cancer chemotherapy-associated dyspepsia in mice","volume":"58","author":"Liu","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib59","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0091-3057(90)90335-F","article-title":"Effects of serotonin antagonists on motion sickness and its suppression by 8-OH-DPAT in cats","volume":"37","author":"Lucot","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.autneu.2006.07.009_bib60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-2999(94)90756-0","article-title":"Antiemetic effects of flesinoxan in cats: comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin","volume":"253","author":"Lucot","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2005.11.017","article-title":"Behavioural and hypothalamic molecular effects of the anti-cancer agent cisplatin in the rat: a model for chemotherapy related malaise?","volume":"83","author":"Malik","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.autneu.2006.07.009_bib62","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1476-5381.1986.tb10228.x","article-title":"Inhibition of cisplatin induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism","volume":"88","author":"Miner","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib63","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bcp.2004.05.019","article-title":"Comparative pharmacology of human D2-like receptor stable cell lines coupled to calcium flux through G\u03b1qo5","volume":"68","author":"Moreland","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib64","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00003495-199243030-00002","article-title":"Pharmacological agents affecting emesis. A review (Part 1)","volume":"43","author":"Mitchelson","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.autneu.2006.07.009_bib65","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1119(03)00503-1","article-title":"Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E","volume":"310","author":"Niesler","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.autneu.2006.07.009_bib66","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1254\/jjp.64.109","article-title":"Antiemetic effects of serotonergic 5-HT1A receptor agonists in Suncus murinus","volume":"64","author":"Okada","year":"1994","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib67","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pbb.2005.03.012","article-title":"Dopamine D2, but not D4, receptor agonists are emetogenic in ferrets","volume":"81","author":"Osinski","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.autneu.2006.07.009_bib68","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuroscience.2005.09.016","article-title":"Inhibition of mechansosensitivity in visceral primary afferents by GABAB receptors involves calcium and potassium channels","volume":"137","author":"Page","year":"2006","journal-title":"Neurosci."},{"key":"10.1016\/j.autneu.2006.07.009_bib69","doi-asserted-by":"crossref","unstructured":"Parker, L.A., Limebeer, C.L., Kwaitkowska, M., 2005. Cannabinoids: effects on vomiting and nausea in animal models. In: Mechoulam, R. (Ed.), Cannabinoids as Therapeutics. Birkhauser Verlag\/Switzerland, pp. 183\u2013200.","DOI":"10.1007\/3-7643-7358-X_10"},{"key":"10.1016\/j.autneu.2006.07.009_bib70","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/gut.2004.062604","article-title":"Ghrelin: a new player in the control of gastrointestinal functions","volume":"54","author":"Peeters","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.autneu.2006.07.009_bib71","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/gast.1997.v113.pm9247457","article-title":"Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation","volume":"113","author":"Penagini","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autneu.2006.07.009_bib72","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(82)92206-1","article-title":"Antiemetics: neurotransmitter receptor binding predicts therapeutic actions","volume":"2","author":"Peroutka","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.autneu.2006.07.009_bib73","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gut.2004.055251","article-title":"Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised double blind, placebo controlled study","volume":"54","author":"Pichet","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.autneu.2006.07.009_bib74","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.autneu.2006.07.009_bib75","series-title":"Serotonin and the Scientific Basis of Anti-Emetic Therapy","first-page":"84","article-title":"The pharmacology of 5-HT release from enterochromaffin cells","author":"Racke","year":"1995"},{"issue":"s2","key":"10.1016\/j.autneu.2006.07.009_bib76","first-page":"69","article-title":"Preferential expression of 5-HT3c, 5-HT3d and 5-HT3e receptor subunits to the gastrointestinal tract of humans and other species","volume":"17","author":"Rance","year":"2005","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.autneu.2006.07.009_bib77","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0090-8258(80)90027-X","article-title":"Methylprednisolone as an antienetic during cancer chemotherapy\u2014a pilot study","volume":"9","author":"Rich","year":"1980","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.autneu.2006.07.009_bib78","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: a new class of potent antitumour agent","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.autneu.2006.07.009_bib79","series-title":"Management of Nausea and Vomiting in Cancer and Cancer Treatment","first-page":"15","article-title":"Mechanisms of acute, delayed, and anticipatory emesis induced by anticancer therapies","author":"Rudd","year":"2005"},{"key":"10.1016\/j.autneu.2006.07.009_bib80","series-title":"Serotonin and the Scientific Basis of Anti-Emetic Therapy","first-page":"208","article-title":"Opioid receptor involvement in emesis and antiemesis","author":"Rudd","year":"1995"},{"key":"10.1016\/j.autneu.2006.07.009_bib81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-2999(99)00285-X","article-title":"Modulation of emesis by fentanyl and apioid receptor antagonist in Suncus murinus (house musk shrew)","volume":"374","author":"Rudd","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib82","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2005.08.062","article-title":"Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin","volume":"392","author":"Rudd","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.autneu.2006.07.009_bib83","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(03)01550-4","article-title":"Action of metyrapone and tetracosactrin to modify cisplatin-induced acute and delayed emesis in the ferret","volume":"466","author":"Sam","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib84","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.2042-7158.1985.tb05108.x","article-title":"Effects of metoclopramide and domperidone on cholinergically-mediated contractions of human isolated stomach muscle","volume":"37","author":"Sanger","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib85","series-title":"Serotonin and the Scientific Basis of Anti-Emetic Therapy","first-page":"155","article-title":"Preclinical differences in 5-HT3 receptor antagonist characteristics","author":"Sanger","year":"1995"},{"key":"10.1016\/j.autneu.2006.07.009_bib86","series-title":"Drug Therapy for Gastrointestinal and Liver Disease","first-page":"45","article-title":"Emesis","author":"Sanger","year":"2001"},{"key":"10.1016\/j.autneu.2006.07.009_bib87","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-0327(96)00075-4","article-title":"Increased prolactin response to buspirone in chronic fatigue syndrome","volume":"41","author":"Sharpe","year":"1996","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.autneu.2006.07.009_bib88","first-page":"342","article-title":"Antiemetic efficacy of smoked marijuana\u2014subjecive and behavioural effects on nausea induced by syrup of ipecac","volume":"69","author":"Soderpalm","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"Suppl 113","key":"10.1016\/j.autneu.2006.07.009_bib90","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/030097400446698","article-title":"Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists-preliminary results","volume":"29","author":"Spath","year":"2000","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.autneu.2006.07.009_bib91","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000154318","article-title":"Asian hypersusceptibility to motion sickness","volume":"46","author":"Stern","year":"1996","journal-title":"Hum. Hered."},{"key":"10.1016\/j.autneu.2006.07.009_bib92","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0959-8049(98)00167-1","article-title":"Fatigue in patients with cancer","volume":"34","author":"Stone","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.autneu.2006.07.009_bib93","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3748\/wjg.v9.i4.779","article-title":"Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice","volume":"9","author":"Suchitra","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.autneu.2006.07.009_bib94","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.neuropharm.2005.06.009","article-title":"Effect of a selective GABAB receptor agonist baclofen on the mu-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects","volume":"49","author":"Suzuki","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.autneu.2006.07.009_bib95","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/annonc\/mdj078","article-title":"Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference","volume":"17","author":"The Antiemetic Subcommittee of the Multinational Association of Supportive care in Cancer (MASCC)","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.autneu.2006.07.009_bib96","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1476-5381.1992.tb14284.x","article-title":"Morphine-6-glucuronide\u2014a metabolite of morphine with greater emetic potency than morphine in the ferret","volume":"106","author":"Thompson","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib97","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2036.2004.01867.x","article-title":"Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics","volume":"19","author":"Tonini","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.autneu.2006.07.009_bib98","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1052-3359(25)00589-7","article-title":"Gastroesophageal reflux disease pathophysiology","volume":"11","author":"Tougas","year":"2001","journal-title":"Chest Surg. Clin. North Am."},{"key":"10.1016\/j.autneu.2006.07.009_bib99","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/S0959-8049(98)00161-0","article-title":"Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting:a quantitative systematic review","volume":"34","author":"Tramer","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.autneu.2006.07.009_bib100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.physiol.68.040504.094635","article-title":"Brainstem circuits regulating gastric function","volume":"68","author":"Travagli","year":"2006","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.autneu.2006.07.009_bib101","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1200\/JCO.2003.05.164","article-title":"Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients","volume":"21","author":"Tremblay","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.autneu.2006.07.009_bib102","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/gast.2001.28466","article-title":"Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret","volume":"121","author":"Van Sickle","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autneu.2006.07.009_bib103","first-page":"G566","article-title":"Tetrahydrocannabinol selectively acts o CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets","volume":"285","author":"Van Sickle","year":"2003","journal-title":"Am. J. Physiol.: Gasterointest. Liver Physiol."},{"key":"10.1016\/j.autneu.2006.07.009_bib104","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0924-977X(95)00070-6","article-title":"Behavioural, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder","volume":"6","author":"van Vliet","year":"1996","journal-title":"Eur. J. Neuropsychopharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib105","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1200\/JCO.2005.09.050","article-title":"Efficacy and tolerability of aprepitant for the prevention and treatment of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy","volume":"23","author":"Warr","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.autneu.2006.07.009_bib106","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bjp.0706157","article-title":"CB1 cannabinoid receptor-mediated modulation of food intake in mice","volume":"145","author":"Wiley","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib107","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1113\/expphysiol.1992.sp003660","article-title":"Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT reuptake inhibitor, reduces the capacity to perform prolonged exercise","volume":"77","author":"Wilson","year":"1992","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.autneu.2006.07.009_bib108","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(97)01401-5","article-title":"Effects of a 5-HT1A receptor agonist on acute and delayed cyclophosphamide-induced vomiting","volume":"340","author":"Wolff","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib109","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0361-9230(98)00092-6","article-title":"Physiological basis and pharmacology of motion sickness","volume":"47","author":"Yates","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.autneu.2006.07.009_bib110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-2999(96)00061-1","article-title":"Involvement of dopamine D3 receptors in the area postrema in R(+)-7-OH-DPAT-induced emesis in the ferret","volume":"301","author":"Yoshikawa","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.autneu.2006.07.009_bib111","first-page":"282","article-title":"Neuroinihibition in the regulation of emesis","volume":"3","author":"Zabara","year":"1972","journal-title":"Space Life Sci."}],"container-title":["Autonomic Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070206002074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070206002074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:54:21Z","timestamp":1761566061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1566070206002074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":108,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S1566070206002074"],"URL":"https:\/\/doi.org\/10.1016\/j.autneu.2006.07.009","relation":{},"ISSN":["1566-0702"],"issn-type":[{"value":"1566-0702","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of nausea and vomiting: Gaps in our knowledge","name":"articletitle","label":"Article Title"},{"value":"Autonomic Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autneu.2006.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}